tag:blogger.com,1999:blog-5574479.post118395465292235863..comments2024-03-28T16:45:51.051+00:00Comments on The IPKat: Regeneron/Bayer v Genentech in Court of Appeal - first instance decision affirmedVerónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5574479.post-22716095273350761262013-02-22T14:01:19.295+00:002013-02-22T14:01:19.295+00:00This is a really nice decision. It's impressiv...This is a really nice decision. It's impressive how inventive step was found when the claims were so barely novel. The Court accepted that the general confusion in the area was enough for the claims to be inventive, which I think is a very sophisticated approach.<br /><br />Regeneron were a bit unlucky I think for the term 'hVEGF receptor' to be interpreted as including fragments of the receptor within a fusion protein. However the dependent claims help to force the broad interpretation (although the decision looks at the description for the interpretation).<br /><br />In addition interesting to note that the patent was not insufficient in as far as it covered the infringement, though making it would require 'ingenuity' not provided by the patent.Sulemanhttp://www.hollyip.comnoreply@blogger.com